Shan Xiuying, Yu Wenjun, Ni Xuejun, Xu Tingting, Lei Chen, Liu Zhaoliang, Hu Xuefeng, Zhang Yanding, Cai Beichen, Wang Biao
Department of Plastic Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou 350005, People's Republic of China.
College of Life Sciences, Fujian Normal University, Fuzhou 350108, People's Republic of China.
Cancer Manag Res. 2020 Aug 20;12:7475-7485. doi: 10.2147/CMAR.S250479. eCollection 2020.
Angiopoietin-2 (Ang-2) has been proven to be a potential agent for malignant cancer treatment. The aim of the current study was to investigate the inhibitory effects of chitosan magnetic nanoparticles (CMNPs) loaded with Ang-2 small interfering RNA (Ang2-siRNA) plasmids (Ang2-CMNPs) on malignant melanoma.
Melanoma-bearing nude mice were treated with Ang2-CMNPs and control CMNPs. Tumor volumes in each group were recorded. Real-time fluorescence quantitative-PCR was used to measure the relative gene expression. Angiogenesis and Ang-2 expression in tumors were measured by immunohistochemistry. Cell apoptosis in each group was measured by TUNEL staining, and the expression of Bax, Bcl-2 and cleaved caspase-3 was analyzed by immunohistochemistry.
The progression of melanoma was significantly inhibited by Ang2-CMNP treatment. Ang2-CMNP treatment efficiently inhibited tumor growth and in-situ Ang-2 expression compared with those of the control group. Furthermore, Ang2-CMNP treatment significantly inhibited tumor angiogenesis and promoted cell apoptosis by regulating the Bax/Bcl-2 ratio and increasing cleaved caspase-3 expression in vivo.
In summary, Ang2-CMNP treatment increased the regression of normal-appearing vessels in the tumor microenvironment and induced the melanoma cells apoptosis through the mitochondrial apoptotic pathway, suggesting the potential clinical use of Ang2-CMNPs in malignant melanoma treatment.
血管生成素-2(Ang-2)已被证明是恶性肿瘤治疗的一种潜在药物。本研究的目的是探讨负载血管生成素-2小干扰RNA(Ang2-siRNA)质粒的壳聚糖磁性纳米颗粒(CMNPs)(Ang2-CMNPs)对恶性黑色素瘤的抑制作用。
将携带黑色素瘤的裸鼠用Ang2-CMNPs和对照CMNPs进行治疗。记录每组的肿瘤体积。采用实时荧光定量PCR检测相对基因表达。通过免疫组织化学检测肿瘤中的血管生成和Ang-2表达。用TUNEL染色检测每组细胞凋亡情况,并用免疫组织化学分析Bax、Bcl-2和裂解的caspase-3的表达。
Ang2-CMNP治疗显著抑制了黑色素瘤的进展。与对照组相比,Ang2-CMNP治疗有效抑制了肿瘤生长和原位Ang-2表达。此外,Ang2-CMNP治疗通过调节体内Bax/Bcl-2比值和增加裂解的caspase-3表达,显著抑制了肿瘤血管生成并促进了细胞凋亡。
总之,Ang2-CMNP治疗增加了肿瘤微环境中正常外观血管的消退,并通过线粒体凋亡途径诱导黑色素瘤细胞凋亡,提示Ang2-CMNPs在恶性黑色素瘤治疗中具有潜在的临床应用价值。